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Available online 30 June 2007AbstractAdenosine is a prototypical neuromodulator, which mainly controls excitatory transmission through the activation of widespread inhibitory A1
receptors and synaptically located A2A receptors. It was long thought that the predominant A1 receptor-meditated modulation by endogenous
adenosine was a homeostatic process intrinsic to the synapse. New studies indicate that endogenous extracellular adenosine is originated as a
consequence of the release of gliotransmitters, namely ATP, which sets a global inhibitory tonus in brain circuits rather than in a single synapse.
Thus, this neuron-glia long-range communication can be viewed as a form of non-synaptic transmission (a concept introduced by Professor
Sylvester Vizi), designed to reduce noise in a circuit. This neuron-glia-induced adenosine release is also responsible for exacerbating salient
information through A1 receptor-mediated heterosynaptic depression, whereby the activation of a particular synapse recruits a neuron-glia network
to generate extracellular adenosine that inhibits neighbouring non-tetanised synapses. In parallel, the local activation of facilitatory A2A receptors
by adenosine, formed from ATP released only at high frequencies from neuronal vesicles, down-regulates A1 receptors and facilitates plasticity
selectively in the tetanised synapse. Thus, upon high-frequency firing of a given pathway, the combined exacerbation of global A1 receptor-
mediated inhibition in the circuit (heterosynaptic depression) with the local synaptic activation of A2A receptors in the activated synapse, cooperate
to maximise salience between the activated and non-tetanised synapses.
# 2007 Elsevier Ltd. All rights reserved.
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Adenosine is a prototypic neuromodulator in the nervous
system, which means it does not trigger direct neuronal
responses but instead fine tunes on-going synaptic transmis-
sion. The impact of adenosine modulation is more evident in the
control of excitatory rather than inhibitory synapses (reviewed
in Dunwiddie and Masino, 2001). The most widely recognised
effects of adenosine are operated through inhibitory A1
receptors, one of the most abundant G protein-coupled
receptors in brain tissue (Dunwiddie and Masino, 2001). A1* Tel.: +351 239 820190; fax: +351 239 822776.
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doi:10.1016/j.neuint.2007.06.026receptors are mainly located in synapses (Rebola et al., 2003),
in particular in glutamatergic synapses (Rebola et al., 2005a).
They are located presynaptically where they inhibit glutamate
release (as well as other neurotransmitters) and post-
synaptically where they inhibit calcium influx through
voltage-sensitive calcium channels and NMDA receptors and
also inhibit potassium currents, leading to membrane hyper-
polarization (reviewed in Fredholm et al., 2005). Altogether,
these physiological functions of adenosine operated through A1
receptors provide a compelling rationale for this modulation
system to fulfil a neuroprotective role in situations of brain
damage (reviewed in de Mendonc¸a et al., 2000). Interestingly,
although the activation of A1 receptors prevents or attenuates
neuronal damage (de Mendonc¸a et al., 2000), evidence is
accumulating to suggest that the neuroprotection afforded by
activation of A1 receptors might be unrelated to its synaptic
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particular the decrease brain metabolism (Ha˚berg et al., 2000;
Duarte et al., 2005) and eventually the control of glia cells
(reviewed in van Calker and Biber, 2005).
There are 3 other adenosine receptors (A2A, A2B and A3
receptors), but their density in brain tissue is lower than that of
A1 receptors. Little is still known about A2B and A3 receptors
due to their low density in brain tissue and to the unavailability
of drugs and antibodies selective for these receptors across
different species (Fredholm et al., 2005). More work has been
devoted to understanding the role of A2A receptors in the brain,
especially in the basal ganglia where they play a prominent role
in the control of psychomotor behaviour (reviewed in Xu et al.,
2005). A2A receptors also play a key role in astrocyte endfeet
controlling microcirculation in the brain since adenosine is an
endproduct generated by astrocytes coupling increased
neuronal activity with vasodilation (reviewed in Phillis,
2004), although other vasoactive substances are also involved
in neurovascular coupling (reviewed in Haydon and Car-
mignoto, 2006). A2A receptors are also present at low density in
different brain areas, namely in cortical areas where they have a
predominant presynaptic localization (Rebola et al., 2005b).
Although A2A receptors have been shown to enhance the
release of different neurotransmitters such as glutamate, their
physiological function in the control of brain circuits is still
unclear (Fredholm et al., 2005). Recently, A2A receptors have
received broader attention because their blockade affords a
robust neuroprotection in different chronic noxious brain
conditions by mechanisms still to be resolved (reviewed in
Cunha, 2005).
2. Effects of endogenous adenosine in brain circuits
Apart from the basal ganglia, the experience of the vast
majority of researchers exploring adenosine modulation is that
adenosine essentially fulfils an inhibitory role mediated by
inhibitory A1 receptors (reviewed in Dunwiddie and Masino,
2001). In particular, the seminal work of Tom Dunwiddie has
revealed that there is an inhibitory tonus mediated by
endogenous adenosine that results from the activation of A1
receptors (Dunwiddie, 1980). This agrees with the general
findings that the addition of exogenous adenosine to integrated
brain preparations causes an inhibition of synaptic transmission
and that no other effect is observed once inhibitory A1 receptors
are blocked or genetically ablated (e.g. Johansson et al., 2001;
Sebastia˜o et al., 1990). This clearly shows that A1 receptors
play by far the predominant role in modulation of brain circuits.
Nevertheless, some studies have revealed particular condi-
tions where it is possible to show that adenosine can also
facilitate the evoked release of neurotransmitters (reviewed in
Cunha, 2001a). Thus, the release of neurotransmitters might be
simultaneously controlled not only by inhibitory A1 but also by
facilitatory A2A receptors (Cunha, 2001a). Indeed, A1 and A2A
receptors can be located in the same synapse (Ciruela et al.,
2006; Rebola et al., 2005a). These observations open the
question of understanding the physiological reason directing
the localization in the same synapse of two receptors withopposite function that are activated by the same ligand with
similar affinities (see Fredholm et al., 2001). In the particular
case of striatal glutamatergic terminals, A1 and A2A receptors
form heterodimers that allow a concentration-dependent switch
from A1 receptor-mediated inhibition into A2A receptor-
mediated facilitation with increasing concentrations of adeno-
sine (Ciruela et al., 2006). However, in other glutamatergic
synapses, such as in the hippocampus, A1 and A2A receptors are
located in the same glutamatergic synapses (Rebola et al.,
2005a) and there is an insurmountable A1 receptor-mediated
inhibition of synaptic transmission with increasing concentra-
tions of adenosine (Johansson et al., 2001; Sebastia˜o et al.,
1990). Thus, at these synapses, other mechanisms should be
considered to understand when A2A receptors will come into
play and this review proposes that this may due to the dynamics
of extracellular adenosine metabolism under different condi-
tions of neuronal firing.
3. Source of endogenous extracellular adenosine
The source of endogenous extracellular adenosine during
physiological conditions of neuronal firing has been one of the
less studied aspects of adenosine neuromodulation. There are
two potential metabolic sources able to generate extracellular
adenosine: (1) release as such, or (2) extracellular formation
from released adenosine nucleotides.
The formation of adenosine from released adenine nucleo-
tides is based on the observation that most cell types in the brain
can release ATP (reviewed in Fields and Burnstock, 2006) and
are endowed with ecto-nucleotidases that are able to convert
extracellular ATP into adenosine (see Cunha, 2001b; Zimmer-
mann, 2000). As shall be detailed, there is now compelling
evidence supporting an important role for this source of
adenosine, at least under physiological conditions (Correia-de-
Sa´ et al., 1996; Cunha et al., 1996a; Dale, 2002; Koizumi et al.,
2003; Newman, 2003; Pascual et al., 2005; Zhang et al., 2003).
The difficulties in highlighting the role of ecto-nucleotidases in
the formation of endogenous extracellular adenosine are
probably related to general lack of pharmacological tools to
manipulate this large family of enzymes (Zimmermann, 2000)
and to the inability to recognise that the ecto-nucleotidase
pathway displays an abnormally efficient kinetic profile
characteristic of fractal kinetics (Cunha et al., 1998; Cunha,
2001b; Dunwiddie et al., 1997). In fact, we know considerably
more about the molecular biology of ecto-nucleotidases than
about their localization and kinetic properties in native tissues
that ultimately define their physiological role. A further major
issue contributing for the inability to highlight the contribution
of ecto-nucleotidases as a source of endogenous extracellular
adenosine might be the different handling of preparations in
order to avoid the massive extracellular accumulation of
adenosine that occurs after different types of insults (reviewed
in Latini and Pedata, 2001). The elegant work of Bruno
Frenguelli and Nicholas Dale has clearly established that the
hypoxia-induced build-up of extracellular adenosine is far
larger than in normoxia and is independent of released ATP, in
contrast to normoxia (Frenguelli et al., 2007).
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adenosine is its release as such. Any situation in which tissue
workload overtakes the availability of metabolic energy leads
to the consumption of ATP (millimolar concentrations in cell),
which causes a disproportionate increase of adenosine
(nanomolar concentration in cells) (see Cunha, 2001a). This
adenosine can then escape cells through bidirectional non-
concentrative nucleoside transporters that are assumed to be
present (still to be experimentally documented) in all cell types
(reviewed in Kong et al., 2004). Although this is the most
widely accepted hypothesis for the build-up of extracellular
adenosine, it has only received episodic experimental
confirmation (e.g. Cunha et al., 2000; MacDonald and White,
1985). Oddly, the effect of pharmacologically manipulating
these nucleoside transporters is an increase of the extracellular
levels of adenosine implying that their role is to take-up rather
than release adenosine (see Fredholm et al., 2005). Thus, in
integrated brain preparations under physiological conditions,
there are no studies directly supporting the contention that
adenosine is released as such through nucleoside transporters.
This situation is different from stressful conditions, where
recent careful studies were left with the remaining hypothesis
that adenosine is released as such (Frenguelli et al., 2007;
Martin et al., 2007; Pearson et al., 2001) through mechanisms
still to be resolved, which may involve carrier systems
(Sperlagh et al., 2003), but independently of nucleoside
transporters.
In contrast to this still debated issue of the metabolic source
of extracellular adenosine, there has been considerable advance
in our understanding of the cellular source of endogenous
extracellular adenosine. The classical view was that adenosine
would fulfil a restricted synaptic role. Thus, adenosinewould be
locally generated in the synapse in amounts directly propor-
tional to synaptic activity, and would act through inhibitory A1
receptors as a feedback mechanism to restraint excessive
synaptic activation (Dunwiddie and Masino, 2001). Two
parallel mechanisms were considered to understand how the
levels of synaptic adenosine would parallel synaptic activity:
(1) adenosine would be formed extracellularly upon catabolism
of released ATP originated from synaptic vesicles (reviewed in
Sperla´gh and Vizi, 1996); (2) adenosine would be released from
the postsynaptic neuron as a consequence of the activation of
ionotropic glutamate receptors (see Dunwiddie and Diao, 1994;
Mitchell et al., 1993a). Irrespective of the source of synaptic
adenosine, the predominance of A1 receptor-mediated inhibi-
tion behaved as a homeostatic ‘autocrine’-like role restricted to
a particular excitatory synapse. However, this scenario suffers
from a major caveat: it does not provide a proper rationale to
understand how synapses could overcome A1 receptor-
mediated inhibition to undergo plastic changes (Mitchell
et al., 1993b). In fact, the supra-maximal activation of A1
receptors is able to block excitatory synaptic transmission.
Since the strength of A1 receptor inhibition should increase
with increasing synaptic activity, then high frequency trains
would generate sufficient extracellular adenosine to block
synaptic transmission in a tetanised synapse (see Cunha et al.,
1996a). Hence one would expect a synaptic block rather than anincrease of synaptic efficiency as is known to occur upon
application of different high frequency trains (Dunwiddie and
Lynch, 1978).
A major twist was recently provided by the group of Phillip
Haydon (Pascual et al., 2005). They generated a transgenic
mouse with astrocytic over-expression of a dominant-negative
form of synaptobrevin-2, which largely abrogates exocytotic
release selectively from astrocytes (Zhang et al., 2004). They
found that this lead to the disappearance of the tonic A1
receptor-mediated inhibition on synaptic transmission in
hippocampal slices (Pascual et al., 2005). This implies that
the endogenous extracellular adenosine responsible for the
tonic A1 receptor-mediated inhibition of excitatory synaptic
transmission is largely derived from astrocytes. Astrocytes
release ATP (reviewed in Fields and Burnstock, 2006; Haydon
and Carmignoto, 2006), which is then extracellularly metabo-
lised into adenosine before activating synaptically located A1
receptors (Koizumi et al., 2003; Newman, 2003; Pascual et al.,
2005; Serrano et al., 2006; Zhang et al., 2003). Thus, there
might actually be an astrocytic ‘‘adenosine-cycle’’ starting with
the astrocytic vesicular release of ATP, its extracellular
degradation to adenosine, its reuptake by equilibrative
nucleoside transporters and its phosphorylation by adenosine
kinase back into ATP (Boison, 2006). This ‘‘adenosine-cycle’’
would be compatible with findings that nucleoside transport
inhibitors lead to an increase of extracellular adenosine, by
preventing intracellular metabolism of adenosine by adenosine
kinase, which would act as the driving force for the astrocytic
reuptake of adenosine. These observations prompted a novel
view on the physiological meaning of this tonic inhibition
mediated by inhibitory A1 receptors. In fact, astrocytes respond
to neuronal activity with a time course considerably slower than
neurons (tenths of seconds versus milliseconds; see Fellin et al.,
2004) and promote broad volume transmission (reviewed in
Halassa et al., 2007; Haydon and Carmignoto, 2006; Scemes
and Giaume, 2006) thanks to their syncytium-like connectivity
(D’Ambrosio et al., 1998; Latour et al., 2001; Wallraff et al.,
2004) and to the number of synapses (near 10,000) contacted by
each astrocyte (Bushong et al., 2003; Ventura and Harris, 1999).
This means that astrocytic-derived adenosine can only be aimed
at setting a global inhibitory tonus as a function of a time-
averaged activity in a broad neuronal circuit. Thus, this
astrocytic source of adenosine implies the concept of slow and
global coordination of synaptic activity in a circuit (i.e. a
‘paracrine’-like modulation) rather that a rapid ‘autocrine’-like
modulation restricted to the synapse, as implied by the classical
view assuming a synaptic source of endogenous extracellular
adenosine tonically activating A1 receptors.
4. Adenosine as a hetero-synaptic modulator—A1
receptors
Several groups noted that the blockade of ecto-nucleotidases
decreases the extracellular levels of endogenous adenosine in
brain slices (Pascual et al., 2005; Martin et al., 2007; Serrano
et al., 2006). In particular, the innovative methodology devised
by Nicholas Dale to quantify on-line the extracellular levels of
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confirmed that the extracellular catabolism of ATP contributed
for the basal extracellular levels of adenosine in slices
stimulated at low frequency (<0.1 Hz) stimulation. Since this
tonic adenosine level is derived from exocytotic release of
gliotransmitters from astrocytes (Pascual et al., 2005), it is
possible to assume that the endogenous extracellular adenosine
is originated from ATP released from astrocytes (it should be
noted that this conclusion is only an assumption still to be
demonstrated: in fact, it remains possible that some glio-
transmitter may indirectly cause the release of ATP and/or
adenosine from neurons). Irrespective of the actual gliotrans-
mitter that is indirectly responsible for the generation of
endogenous extracellular adenosine, it should be pointed out
that it is constitutively released in slices, albeit Ca2+ waves,
indicative of astrocytic activation (Dani et al., 1992; reviewed
in Halassa et al., 2007; Scemes and Giaume, 2006), are scarcely
observed upon low frequency stimulation of adult brain
preparations (Hirase et al., 2004; Newman, 2003; see also
Grosche et al., 1999; Pasti et al., 1997). But from the functional
point of view, this astrocytic-driven constitutive generation of
endogenous extracellular adenosine has an important correlate:
it means that the tonic A1 receptor-mediated inhibition of
excitatory synaptic transmission is likely designed to act
globally in brain circuits to decrease noise in excitatory circuits.
This long-distance A1 receptor-mediated inhibition operated
by endogenous extracellular adenosine also fits beautifully with
the idea that adenosine is the main messenger mediating hetero-
synaptic depression (Manzoni et al., 1994). This consists in the
observation that a high frequency stimulation of a particular
excitatory pathway causes a depression in nearby pathways
(Lynch et al., 1977). When first described, this was proposed to
depend on the recruitment on interneurons (Manzoni et al.,
1994). This was confirmed in a recent elegant study which
established that the high frequency stimulation of a set of
Schaffer fibers in hippocampal slices led to the sequential
activation of NMDA receptors in GABAergic interneurons and
the GABA released would trigger astrocytic activation through
GABAB receptors (Kang et al., 1998; Serrano et al., 2006);
thanks to the long-range propagation of Ca2+ waves in
astrocytic syncytium (up to 100 mm; reviewed in Halassa
et al., 2007; Haydon and Carmignoto, 2006; Scemes and
Giaume, 2006), the astrocytes could release ATP in sites facing
distant non-stimulated synapses (Pascual et al., 2005; Serrano
et al., 2006; Zhang et al., 2003), which, upon extracellular
degradation by ecto-nucleotidases, would activate A1 receptors
in these distant non-stimulated synapses (Serrano et al., 2006).
This heterosynaptic depression triggered in a group of
neighbouring excitatory synapses as a result of the high-
frequency stimulation of a particular synapse has an important
physiological role: it is designed to increase contrast between
activated synapses undergoing plastic changes and non-
tetanised synapses (Lynch et al., 1977; Serrano et al., 2006).
One expected correlate is that the decrease of this A1 receptor-
mediated heterosynaptic depression might facilitate synchro-
nization of neuronal activity, which has been proposed to cause
seizures (see Halassa et al., 2007).5. Adenosine as a synaptic modulator—A2A receptors
This ‘paracrine’-like role of adenosine acting broadly in
large groups of synapses in a non-synaptic (Vizi, 1984) or
volume transmission-like manner (Agnati et al., 1986) should
not underscore a complementary role fulfilled by adenosine as
an ‘autocrine’-like signalling molecule restricted to a
particular synapse. In fact, there is ground to propose that
the role of adenosine in the control of synaptic plasticity might
not only be limited to the ‘paracrine’-like action of inhibitory
A1 receptors, but is supplemented by an ‘autocrine’-like role of
facilitatory A2A receptors restricted to activated synapses
(reviewed in Ferre´ et al., 2005). In fact, several studies have
shown that stimulated nerve terminals can directly release
ATP, which is stored in synaptic vesicles (reviewed in Sperla´gh
and Vizi, 1996). However, this stimulation-evoked release of
ATP from nerve terminals seems to differ from the release of
classical neurotransmitters (Farinas et al., 1992; Magalha˜es-
Cardoso et al., 2003; Rabasseda et al., 1987; Santos et al., 1999;
see also Coco et al., 2003). In particular, this release of ATP is
disproportionally larger at higher frequencies of nerve
stimulation (Cunha et al., 1996a; Wieraszko et al., 1989).
We have recently confirmed that this release of ATP from
hippocampal nerve terminals required greater intensities of
stimulation than these required to trigger the release of
glutamate, GABA or acetylcholine and also involves the
recruitment of L-type calcium channels rather than N- or P-
type calcium channels (Rodrigues et al., 2004). Also, we have
found that the extracellular catabolism of released adenine
nucleotides in synapses is not associated with the activation of
inhibitory A1 receptors, but rather with the activation of
facilitatory A2A receptors (Cunha et al., 1996b). Furthermore,
we have shown that the activation of A2A receptors can down-
regulate A1 receptors via different mechanisms: in hippo-
campal synapses, A2A receptor activation operate a protein
kinase C-dependent pathway to down-regulate A1 receptors
(Lopes et al., 1999); in contrast in cortico-striatal glutama-
tergic nerve terminals, A1 and A2A receptors form hetero-
dimers and A2A receptor activation by increasing concentra-
tions of adenosine down-regulates A1 receptor-mediated
responses (Ciruela et al., 2006). Finally, we also found that
the activation of these A2A receptors by endogenous adenosine
is required to sustain NMDA receptor-dependent synaptic
plasticity in hippocampal synapses (Costenla et al., 2004;
Rebola et al., 2006), the same occurring in the basal ganglia
(D’Alcantara et al., 2001).
This support a role for an ‘autocrine’-like facilitation
operated by A2A receptors that are activated by adenosine
formed from neuronally released ATP (see Cunha, 2001a).
This facilitation is restricted only to tetanised synapses where
extracellular ATP is generated in sufficient amounts to
activate A2A receptors (Almeida et al., 2003). This might
only occurs upon high-frequency stimulation, characteristic
of long-term potentiation. Thus, this local stimulation of
A2A receptors restricted to the tetanised stimulated synapses
has a double importance: it directly promotes the NMDA
receptor-mediated plastic changes triggered by high-fre-
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A1 receptor-mediated inhibition. Therefore, it is a local
mechanism to facilitate the implementation of synaptic
plasticity.Fig. 1. In resting conditions, astrocytic-derived extracellular adenosine maintains a ton
excitatory circuits (upper panel). When a synapse is activated by tetanisation, the A1
activated synapses andA2A receptors are selectively recruited in the activated synapse t
upper panel illustrates a resting condition of functioning of a neuronal circuit, where
astrocytes tonically releasevesicular ATP,which is extracellularly catabolised by ecton
tonically inhibit both excitatory, releasing glutamate (Glu). The lower panel illustrates
frequency firing. In this synapse, high-frequency stimulation now leads to the release
nucleotidases forming adenosine that is directed to the activation of facilitatoryA2A rec
A1 receptors. The overall result is a potentiation of this activated synapse. In parallel, g
dependent activation of interneurons (not presented) to trigger a calcium wave in astr
synapses. As described for the upper panel, this ATP is catabolised by ecto-nucleot
Therefore, the combined action ofA2A receptors in the activated synapse and ofA1 rece
a high-frequency train. (For interpretation of the references to color in this figure leg6. An integrated view of adenosine modulation
Overall, the ‘paracrine’-like role of A1 receptor-mediated
inhibition and the ‘autocrine’-like facilitatory role of A2Aic A1 receptor-mediated inhibition of excitatory transmission to decrease noise in
receptor-mediated heterosynaptic depression further decreases activity of non-
o locally shut-downA1 receptors and promote the potentiation of this synapse. The
two synapses (in grey) are connected by an astrocytic syncytium (in blue). The
ucleotidases (E, inviolet) forming adenosine that activatesA1 receptors (in blue) to
a condition where one of the synapses (in the left) is activated by a burst of high-
of presynaptic vesicles containing ATP. This ATP is degraded by synaptic ecto-
eptors (in red). TheseA2A receptors facilitate glutamate release and down-regulate
lutamate triggers a heterosynaptic depression. This starts by an NMDA receptor-
ocytes (in yellow). This leads to a greater release of ATP in distal non-activated
idases and activates A1 receptors to further depress this non-activated synapse.
ptors in non-activated synapses increase salience of information processing during
end, the reader is referred to the web version of the article.)
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between stimulated and non-tetanised synapses (Fig. 1). At low
frequencies of nerve stimulation (used in the majority of
studies), it is only possible to highlight a role of A1 receptors,
which impose a global tonic inhibition of excitatory transmis-
sion designed to decrease noise (Fig. 1, upper panel).
Facilitatory A2A receptors only come into play when
frequency-coded information arrives at a given synapse in
the form of a high frequency train of action potentials. In the
tetanised synapse, ATP is released and catabolised to activate
A2A receptors which play a double role: they facilitate synaptic
plasticity and they down-regulate A1 receptors selectively in the
activated synapse. In parallel, through the recruitment of an
interneuron-astrocytic network, there is a global increase of
extracellular adenosine implementing a heterosynaptic depres-
sion in all neighbouring synapses (Fig. 1, lower panel). This
cooperation between the activation of A2A receptors in
activated synapses and A1 receptors in non-activated synapses
may be a fine-tuning mechanism increasing salience of
information processing in activated versus non-tetanised
pathways in brain circuits.
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